Clinical trials
Active, not recruiting Glioma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 84 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 17 |
| City of Hope Medical Center | 4 |
| M.D. Anderson Cancer Center | 4 |
| Cellectar Biosciences, Inc. | 2 |
| Children's Oncology Group | 2 |
| David W. Roberts | 2 |
| Eli Lilly and Company | 2 |
| Massachusetts General Hospital | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| NYU Langone Health | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 84 |
| Glioblastoma | 35 |
| Brain Neoplasms | 22 |
| Astrocytoma | 17 |
| Medulloblastoma | 16 |
| Ependymoma | 15 |
| Central Nervous System Neoplasms | 12 |
| Neuroblastoma | 11 |
| Oligodendroglioma | 11 |
| Rhabdoid Tumor | 11 |
Trials
Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.